EFRAT TSABARI: Open Payments
NPI 1508355801 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$819 in 31 payments from 15 companies in 2025. Trend: 2023 $291 · 2024 $1,479 · 2025 $819
Food & beverage: $819
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 6 | $246 |
| Paratek Pharmaceuticals, Inc. | 3 | $75 |
| United Therapeutics Corporation | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| ViiV Healthcare Company | 2 | $45 |
| ABBVIE INC. | 2 | $44 |
| JAZZ PHARMACEUTICALS INC. | 2 | $42 |
| Lilly USA, LLC | 2 | $37 |
| Insmed, Inc. | 2 | $36 |
| Grifols USA, LLC | 1 | $34 |
Products named: Yeztugo, NUZYRA, Tyvaso, GLASSIA, CABENUVA, RYLAZE, ZEPBOUND, Arikayce.
Industry payments across TX — which companies pay providers there.
